SCI Abstract

search
+
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma
The management of marginal zone lymphoma (MZL), an indolent B-cell non-Hodgkin lymphoma, requires a personalized and adapt...
Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
Multiple myeloma (MM) is classified as a lymphoproliferative disorder that remains an incurable malignancy despite improve...
Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies
Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies
Gastrointestinal stromal tumors (GIST) are the most common gastrointestinal soft tissue sarcomas, with an incidence of abo...
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy
Colorectal cancer, ranking as the third most prevalent malignancy globally, substantially benefits from both immunotherapy...
Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients
Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients
Gastric cancer (GC) is a deadly disease worldwide, and trastuzumab in combination with chemotherapy has been the standard ...
Unlocking the Therapeutic Potential of Natural Polyphenols in Esophageal Cancer
Unlocking the Therapeutic Potential of Natural Polyphenols in Esophageal Cancer
Esophageal cancer (EC), one highly malignant upper gastrointestinal cancer, is the eighth most commonly occurring cancer a...
Advances in PSMA-Targeted Radionuclide Therapeutics
Advances in PSMA-Targeted Radionuclide Therapeutics
Prostate-specific membrane antigen targeted radionuclide therapies (PSMA-TRT) such as 177Lu-PSMA-617 hold great promise in...
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment
Metastatic bone disease (MBD) is a significant source of morbidity and mortality in cancer patients with solid tumors, inc...
Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies
Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies
Hematological malignancies are common among older adults, a group that faces unique challenges in treatment. While hematop...
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview
Pancreatic cancer (PC) remains the deadliest cancer worldwide. Most patients are diagnosed at the advanced or metastatic s...
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
The introduction of TKIs into the therapeutic armamentarium of CML has changed the disease paradigm, increasing long-term ...
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
Given the considerable heterogeneity in neuroendocrine neoplasms (NENs), it appears unlikely that a sole biomarker exists ...
Updates in Management of Malignant Pleural Mesothelioma
Updates in Management of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable. A...
The Evolving Treatment Landscape of Medullary Thyroid Cancer
The Evolving Treatment Landscape of Medullary Thyroid Cancer
Genetic assessment is crucial to address the correct treatment for advanced medullary thyroid cancer (MTC). Multi tyrosine...
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
The primary objective of this study is to evaluate the effectiveness of cancer vaccines containing genetically modified de...
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Standard frontline treatment of metastatic colorectal cancer (CRC) is cytotoxic chemotherapy plus a biologic agent such as...
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Approximately 15–20% of breast cancers (BC) demonstrate HER2 overexpression/gene amplification. Historically, before...
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Inflammatory myofibroblastic tumor (IMT), characterized by intermediate malignancy and a propensity for recurrence, has pr...
Frontiers of Ovarian Carcinosarcoma
Frontiers of Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS), also known as a malignant mixed Müllerian tumour (MMMT), is a rare and aggressive form ...
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver,...
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a fatal blood malignancy. With the development of immunotherapy, particularly chimeric ant...
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
The therapeutic approach of pleomorphic liposarcoma (PLPS), a rare high-grade subgroup of soft tissue sarcoma, is commonly...
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Multiple treatment options are now approved for unresectable hepatocellular carcinoma (HCC). An immune checkpoint inhibito...
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Cite this articlePatel, M., Hudson, O., Han, J. et al. Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint I...
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Strategies using immune checkpoint inhibitors (ICI), which can enhance antitumor immune responses, have revolutionized the...
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Esophageal cancer is a global health problem, which is 7th most common and 6th most deadly cancer. It has been the era of ...
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Department of Medicine, University of Melbourne, Victoria Pde, Fitzroy, Melbourne, Victoria, 3065, AustraliaJennifer Phili...
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Central nervous system (CNS) radiotoxicity remains a challenge in neuro-oncology. Dose distribution advantages of protons ...
The Crying Need for a Better Response Assessment in Rectal Cancer
The Crying Need for a Better Response Assessment in Rectal Cancer
Since total neoadjuvant treatment achieves almost 30% pathologic complete response, organ preservation has been increasing...
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced neurotoxicity (OINT) is a neuropsychiatric syndrome observed with opioid therapy. The mechanism of OINT is ...
Load More
format_indent_increase